left
Hey There : )
right
company-image

Unlisted Shares

Care Health Essentials

As of July 27, 2024, Care Health Insurance, Unlisted Shares are trading at ₹185.00 per share, with a 52-week high of ₹210 and 52-week low of ₹178. The minimun lot size is 1025 shares, and the shares are traded on NSDL and CDSL.

ISIN

INE119J01011

Face Value

₹ 10

Total Share

94,22,30,610

Total Income

₹ 4,215.95 undefined

Profit After Tax

₹ ****

EPS

₹ ****

P/E

****

P/B

****

Market Capitalisation

₹ 17,431.27 Cr

Enterprise Value

₹ ****

Book Value

₹ 16.09

Intrinsic Value

₹ ****

Earnings Yield

1.43 %

Sector

Financials

Sub-sector

Insurance

Category

Upcoming IPO

Cashflow - Operations

102.92

Cashflow - Financing

295.75

Care Health Growth

Compounded Sales Growth

1 Year

3 Year

6 Year

Compounded Profit Growth

1 Year

3 Year

6 Year

Return On Equity

2018

2021

2023

Highlights

image
  • Growing Top and Bottomline: Over the past five years, the company's revenue increased at a compound annual growth rate (CAGR) of 450%, while its net profit grew at a CAGR of 272.15%. In FY23, revenue grew by 53.31%, and net profit grew by 2039.6%.
image
  • Increasing Gross Direct Premium: In FY23, the company became the second-largest standalone health insurer (SAHI) in terms of Gross Direct Premium, with a growth of 32.48% to Rs. 5237.69 Cr.
image
  • Growing AUM: Over the last five years, the company's assets under management have grown at a compound annual growth rate of 31.23%. In FY23, the assets under management grew by 38.54%.
image
  • Prominent Investors: Care Health has Religare Enterprise Ltd as the major shareholder (64.98%), followed by Kedaara Capital Ltd (16.36%) and Union Bank of India (5.45%).
image
  • Investment Thesis: The company's operating profitability has improved with a combined ratio of 92.27%, and it is becoming a major player among standalone health insurers. However, its valuation appears to be relatively overpriced as compared to its peers. It is currently trading at a P/E of 70.9x, which is higher than the average P/E of its peers, which is 48.4x. Moreover, the company's P/B ratio is also trading at a higher value of 11.7x as compared to the average P/B ratio of its peers, which is 4.3x. 
  • Potential Governance Red Flag: The company issued ESOPs worth Rs. 250 Cr. to the non-executive director Dr. Rashmi Saluja without informing the shareholders of the parent company Religare. (Source Economic Times, dated 17 Nov 2023)

Business Rating

image

Managment

lock starlock starlock starlock starlock star
image

Accounting Practice

lock starlock starlock starlock starlock star
image

Profatibility

lock starlock starlock starlock starlock star
image

Solvency

lock starlock starlock starlock starlock star
image

Growth

lock starlock starlock starlock starlock star
image

Valuation

lock starlock starlock starlock starlock star

Overall Ratings

lock starlock starlock starlock starlock star

Recommendation

lock starlock starlock starlock starlock star

Our Team

directorImage

Mr. Anuj Gulati

( Managing director & CEO )

“A good health index is the fulcrum for a progressive and productive society. We look forward to initiatives that will help facilitate access to quality healthcare for all stratas of the population. Since health insurance is an effective healthcare financing tool, it will be beneficial to have programs that drive health insurance enrolment and therefore address the challenges of under-penetration and inadequate coverage.”

Quantity

Invest

, Min. Investment: ₹